Cystatin C and mortality risk in the general population: systematic review and dose response meta-analysis-Reference-Cited by-同舟云学术

Cystatin C and mortality risk in the general population: systematic review and dose response meta-analysis

Published:2021-12-01 Issue: Volume: Page:1-24
ISSN:1354-750X
Container-title:Biomarkers
language:en
Short-container-title:Biomarkers

Author:

Jung Eujene¹,Ro Young Sun²,Ryu Hyun Ho¹³,Kong So Yeon⁴,Shin Sang Do²,Hwang Sung Oh⁵

Affiliation:

1. Department of Emergency medicine, Chonnam National University Hospital, South Korea

2. Department of Emergency Medicine, Seoul National University College of Medicine, South Korea

3. Chonnam National University College of Medicine, South Korea

4. Laerdal, Norway

5. Department of Emergency Medicine, Yonsei University Wonju College of Medicine, South Korea

Funder

Korea Centers for Disease Control and Prevention

Chonnam National University Hwasun Hospital

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Clinical Biochemistry,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/1354750X.2021.1989489

Reference37 articles.

1. Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: Final Data for 2013. National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 2016;64(2):1-119.

2. Coll E, Botey A, Alvarez L, Poch E, Quinto L, Saurina A, et al. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2000;36(1):29-34.

3. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2002;40(2):221-6.

4. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney international. 1995;47(1):312-8.

5. Shlipak MG, Katz R, Sarnak MJ, Fried LF, Newman AB, Stehman-Breen C, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Annals of internal medicine. 2006;145(4):237-46.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cystatin C and sarcopenia index are associated with cardiovascular and all-cause death among adults in the United States;BMC Public Health;2024-07-23

2. Functional state of the kidneys in patients with acute coronary syndrome against the background of newly identified disorders of carbohydrate metabolism: a multidisciplinary problem;Expert Review of Endocrinology & Metabolism;2024-06-03

3. Cystatin C and sarcopenia index are associated with all-cause and cardiovascular death among adults in the United States;2023-11-15

4. Cystatin C to Left Ventricular Ejection Fraction Ratio as a Novel Predictor of Adverse Outcomes in Patients with Coronary Artery Disease: A Prospective Cohort Study;Reviews in Cardiovascular Medicine;2023-09-18

5. No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank;Frontiers in Medicine;2023-08-17